Jim Nelson

Intellectual Property

About Jim Nelson

Schwegman, Lundberg & Woessner

121 S 8th St #1600 Minneapolis, Minnesota 55402

jnelson@slwip.com

(612) 373-6939

View Lawyer's Website

Topics Addressed by This Lawyer

BioSimilars

Naming Problems with BioSimilars

Biologics vs Small Molecules

BioSimilar Patenting Litigation Involving Large Amounts of Money

Why Are Biologicals so Important?

Demonstrating BioSimilarity Under U.S. Law

Biologics Price Competition and Innovation Act

Claim Maps and BioSimilars

What is a BioSimilar?

How to Navigate BioSimilar Challenges

Litigation and BioSimilar Patenting

Are BioSimilars Being Approved in the US?

Who Determines Substitution Factors?

FDA Guidelines for Demonstrating Biosimilarity

Merrifield Synthesis

Impact of US Hatch Waxman Act 1984

Approvals of BioSimilars in Europe

Sponsor

What is a BioSimilar Product Under US Law?

Top Rated Intellectual Property Law

Rewards of the Practice

Technical Background

Experience

Top Rated Intellectual Property Law Firm

Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals